JP2013531993A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013531993A5 JP2013531993A5 JP2013515568A JP2013515568A JP2013531993A5 JP 2013531993 A5 JP2013531993 A5 JP 2013531993A5 JP 2013515568 A JP2013515568 A JP 2013515568A JP 2013515568 A JP2013515568 A JP 2013515568A JP 2013531993 A5 JP2013531993 A5 JP 2013531993A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fragment
- seq
- influenza
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35597810P | 2010-06-17 | 2010-06-17 | |
| US61/355,978 | 2010-06-17 | ||
| US201161443103P | 2011-02-15 | 2011-02-15 | |
| US61/443,103 | 2011-02-15 | ||
| US201161445455P | 2011-02-22 | 2011-02-22 | |
| US61/445,455 | 2011-02-22 | ||
| PCT/US2011/040982 WO2011160083A1 (en) | 2010-06-17 | 2011-06-17 | Antibodies useful in passive influenza immuization |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013531993A JP2013531993A (ja) | 2013-08-15 |
| JP2013531993A5 true JP2013531993A5 (https=) | 2014-07-31 |
| JP6050747B2 JP6050747B2 (ja) | 2016-12-21 |
Family
ID=45348575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013515568A Active JP6050747B2 (ja) | 2010-06-17 | 2011-06-17 | インフルエンザ受動免疫化に有用な抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10676520B2 (https=) |
| EP (1) | EP2582721B1 (https=) |
| JP (1) | JP6050747B2 (https=) |
| KR (1) | KR101849738B1 (https=) |
| CN (2) | CN106397584A (https=) |
| AU (2) | AU2011268072C1 (https=) |
| BR (1) | BR112012032185A2 (https=) |
| CA (1) | CA2839421C (https=) |
| DK (1) | DK2582721T3 (https=) |
| ES (1) | ES2687706T3 (https=) |
| RU (1) | RU2635999C2 (https=) |
| WO (1) | WO2011160083A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX367743B (es) | 2011-12-05 | 2019-09-04 | Trellis Bioscience Llc | Anticuerpos utiles para la inmunizacion pasiva de influenza. |
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| CN104968367B (zh) | 2012-11-13 | 2018-04-13 | 弗·哈夫曼-拉罗切有限公司 | 抗血凝素抗体和使用方法 |
| MX387277B (es) | 2013-03-14 | 2025-03-12 | Contrafect Corp | Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada. |
| US10639370B2 (en) * | 2014-02-04 | 2020-05-05 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
| JP6712428B2 (ja) | 2014-02-04 | 2020-06-24 | コントラフェクト コーポレイション | インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法 |
| CA2940319A1 (en) * | 2014-03-20 | 2015-09-24 | Inflarx Gmbh | Inhibitors of c5a for the treatment of viral pneumonia |
| TWI702229B (zh) | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| EP3374390A1 (en) | 2015-11-13 | 2018-09-19 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| AU2017222564A1 (en) | 2016-02-24 | 2018-09-06 | Visterra, Inc. | Formulations of antibody molecules to influenza virus |
| BR112019000098A2 (pt) * | 2016-07-14 | 2019-04-09 | Bioarctic Ab | proteína de fornecimento ao cérebro, método de tratamento e/ou profilaxia de distúrbios cerebrais em mamíferos que possuem ou encontram-se em risco de desenvolver o mencionado distúrbio e método de diagnóstico e/ou detecção de distúrbios cerebrais em mamíferos suspeitos de possuir ou que se encontram em risco de desenvolver o mencionado distúrbio |
| CN111989115A (zh) * | 2017-12-29 | 2020-11-24 | 财团法人生物技术开发中心 | 针对流感的通用疫苗 |
| US11780907B2 (en) | 2018-01-26 | 2023-10-10 | Regeneron Pharmaceuticals, Inc. | Human antibodies to influenza hemagglutinin |
| US11230593B2 (en) | 2019-03-25 | 2022-01-25 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235708B1 (en) | 1998-11-20 | 2001-05-22 | Zymogenetics, Inc | Testis-specific cystatin-like protein cystatin T |
| US20020006656A1 (en) | 1999-12-23 | 2002-01-17 | Holloway James L. | Zcys5: a member of the cystatin superfamily |
| AU2003210060B2 (en) | 2002-03-22 | 2010-02-25 | Aprogen, Inc. | Humanized antibody and process for preparing same |
| KR20050114225A (ko) | 2003-03-07 | 2005-12-05 | 머크 앤드 캄파니 인코포레이티드 | 인플루엔자 바이러스 백신 |
| SG128680A1 (en) * | 2003-07-22 | 2007-01-30 | Crucell Holland Bv | Binding molecules against sars-coronavirus and uses thereof |
| RU2366662C2 (ru) * | 2003-07-23 | 2009-09-10 | Фуджирибайо Инк. | Моноклональное антитело к вирусу типа а гриппа и устройство для иммунного анализа с использованием антитела |
| US7413868B2 (en) | 2003-11-05 | 2008-08-19 | Trellis Bioscience, Inc. | Use of particulate labels in bioanalyte detection methods |
| WO2007134327A2 (en) * | 2006-05-15 | 2007-11-22 | Sea Lane Biotechnologies, Llc. | Neutralizing antibodies to influenza viruses |
| EP2450377A1 (en) * | 2006-09-07 | 2012-05-09 | Crucell Holland B.V. | Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
| RU2448979C2 (ru) * | 2006-12-14 | 2012-04-27 | Ридженерон Фармасьютикалз, Инк. | Антитела человека к дельта-подобному лиганду-4 человека |
| RU2010127156A (ru) * | 2007-12-06 | 2012-01-20 | Дана-Фарбер Кэнсер Инститьют, Инк. (Us) | Антитела против вируса гриппа и их применение |
| JP2011516423A (ja) * | 2008-03-28 | 2011-05-26 | シー レーン バイオテクノロジーズ， エルエルシー | ウイルス抗原に対する中和分子 |
| CA2731686C (en) | 2008-07-25 | 2020-04-07 | Institute For Research In Biomedicine | Neutralizing anti-influenza a virus antibodies and uses thereof |
| TW201019959A (en) * | 2008-08-19 | 2010-06-01 | Regeneron Pharma | Human antibodies to human RANKL |
| AU2008365616A1 (en) | 2008-12-24 | 2011-08-11 | Temasek Life Sciences Laboratory Limited | Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof |
| US20130022608A1 (en) | 2010-03-26 | 2013-01-24 | Pomona Ricerca S.R.L. | FULL-LENGTH IgG IMMUNOGLOBULINS CAPABLE OF RECOGNIZING A HETEROSUBTYPE NEUTRALIZING EPITOPE ON THE HEMAGGLUTININ STEM REGION AND USES THEREOF |
| CA2807664A1 (en) * | 2010-08-12 | 2012-02-16 | Theraclone Sciences, Inc. | Anti-hemagglutinin antibody compositions and methods of use thereof |
| WO2012045001A2 (en) * | 2010-09-30 | 2012-04-05 | Vanderbilt University | Influenza virus antibodies and immunogens and uses therefor |
-
2011
- 2011-06-17 KR KR1020137001292A patent/KR101849738B1/ko not_active Expired - Fee Related
- 2011-06-17 DK DK11796555.8T patent/DK2582721T3/en active
- 2011-06-17 ES ES11796555.8T patent/ES2687706T3/es active Active
- 2011-06-17 RU RU2013102073A patent/RU2635999C2/ru active
- 2011-06-17 WO PCT/US2011/040982 patent/WO2011160083A1/en not_active Ceased
- 2011-06-17 BR BR112012032185A patent/BR112012032185A2/pt not_active IP Right Cessation
- 2011-06-17 US US13/163,489 patent/US10676520B2/en active Active
- 2011-06-17 JP JP2013515568A patent/JP6050747B2/ja active Active
- 2011-06-17 CA CA2839421A patent/CA2839421C/en not_active Expired - Fee Related
- 2011-06-17 CN CN201610806357.8A patent/CN106397584A/zh active Pending
- 2011-06-17 CN CN201180035923.5A patent/CN103209994B/zh not_active Expired - Fee Related
- 2011-06-17 AU AU2011268072A patent/AU2011268072C1/en not_active Ceased
- 2011-06-17 EP EP11796555.8A patent/EP2582721B1/en active Active
-
2017
- 2017-06-09 AU AU2017203924A patent/AU2017203924B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013531993A5 (https=) | ||
| AU2021245146B2 (en) | Influenza A virus specific antibodies | |
| CN104892753B (zh) | 一种中和人感染h7n9甲型流感病毒的抗体及其用途 | |
| Lee et al. | Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies | |
| RU2013102073A (ru) | Антитела, подходящие для пассивной иммунизации против гриппа | |
| HRP20201975T1 (hr) | Neutralizirajuća protutijela anti-influenca a virusa i njihova uporaba | |
| JP6371222B2 (ja) | インフルエンザの受動免疫用抗体 | |
| JP2011528901A5 (https=) | ||
| HRP20161740T1 (hr) | Ljudske molekule za vezanje koje su sposobne neutralizirati viruse influence a filogenetske skupine 1 i filogenetske skupine 2, te viruse influence b | |
| JP2010521147A5 (https=) | ||
| JP2014237714A5 (https=) | ||
| JP2016503413A5 (https=) | ||
| JP2010502207A5 (https=) | ||
| JP2011528902A5 (https=) | ||
| JP2015522252A5 (https=) | ||
| JP2013501807A5 (https=) | ||
| CN105985433B (zh) | 针对h7n9亚型禽流感病毒的全人源单克隆抗体及应用 | |
| CN111094335A (zh) | 广泛中和的抗流感单克隆抗体及其用途 | |
| CN101993492B (zh) | 抗H5N1型高致病性禽流感scFv抗体及其应用 | |
| CN107216387B (zh) | 一种b型流感病毒广谱中和抗体、其制备方法及应用 | |
| Wu et al. | Allosteric Neutralization by Human H7N9 Antibodies | |
| Jia et al. | Allosteric Neutralization by Human H7N9 Antibodies | |
| Voronina et al. | Cross-reactive single-domain antibodies to hemagglutinin stem region protect mice from group 1 influenza A virus infection | |
| Wyrzucki et al. | Characterization of Influenza A-neutralizing, Heterosubtypic Antibodies Isolated with a Newly Developed Antigen | |
| NZ626716B2 (en) | Antibodies useful in passive influenza immunization |